Appetite Clinical Trials

10 recruiting

Appetite Trials at a Glance

10 actively recruiting trials for appetite are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Cambridge, Erzurum, and Gothenburg. Lead sponsors running appetite studies include Göteborg University, Hacettepe University, and Chief investigator Dr Alison Poulton.

Browse appetite trials by phase

Treatments under study

About Appetite Clinical Trials

Looking for clinical trials for Appetite? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Appetite trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Appetite clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Not Applicable

Assessing the Appearance of Amino Acids in Circulation Following Consumption of Protein Beverages

Gastrointestinal TolerabilityAppetiteAmino Acids
Midwest Center for Metabolic and Cardiovascular Research30 enrolled1 locationNCT07293091
Recruiting
Not Applicable

Metabolic Effects of Short-term Ultra-processed Food Intake (MEST-UPF)

Obesity and Obesity-related Medical ConditionsAppetite
Göteborg University24 enrolled1 locationNCT07213245
Recruiting
Not Applicable

Effects of a Collagen Supplement on Quality of Life, Appetite and Glycaemic Control

EnergyQuality of LifeSleep+3 more
King's College London100 enrolled1 locationNCT07229014
Recruiting
Not Applicable

Interaction Between White Potato Consumption and Meal Timing on Glycemic Response and Appetite in Adults

HealthyAdultAppetite+2 more
Toronto Metropolitan University30 enrolled1 locationNCT07230951
Recruiting

Hormonal, Metabolic, and Signaling Interactions in PAH

Idiopathic Pulmonary Arterial HypertensionHeritable Pulmonary Arterial HypertensionScleroderma Associated Pulmonary Arterial Hypertension+1 more
Vanderbilt University Medical Center1,899 enrolled1 locationNCT01884051
Recruiting
Not Applicable

Hypoxia, Appetite, and Energy Intake in Young Female Adults

HypoxiaAppetiteAltitude
University of Ottawa10 enrolled1 locationNCT06912230
Recruiting
Not Applicable

Investigation of the Effect of Date Consumption on Hedonic Hunger and Appetite in Adult Individuals With Type 2 Diabetes

Type 2 Diabetes MellitusAppetite
Hacettepe University64 enrolled1 locationNCT06826235
Recruiting

Neurobehavioural and Cognitive Changes in Cancer Cachexia (CANCOG)

CancerWeight LossCachexia+2 more
University of Cambridge50 enrolled1 locationNCT06112964
Recruiting
Not Applicable

Exogenous Ketones and Appetite

ObesityAppetiteKetones+1 more
University of British Columbia22 enrolled1 locationNCT06327464
Recruiting

Investigation of the effect of a single dose of stimulant medication (dexamphetamine 10mg or methylphenidate 20mg) on appetite and on fasting and postprandial levels of insulin, glucose, leptin and ghrelin in healthy adult volunteers.

Appetite suppression on stimulant medication. This is the presumed reason for the weight loss that usually occurs when children with attention deficit hyperactivity disorder (ADHD) are treated with dexamphetamine or methylphenidate.
Chief investigator Dr Alison Poulton12 enrolled1 locationACTRN12607000138482